Atea Pharmaceuticals shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Atea Pharmaceuticals (AVIR) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Atea Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Atea Pharmaceuticals held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Atea Pharmaceuticals by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $698k | 229k | 3.05 |
| 2023-09-30 | $783k | 261k | 3.00 |
| 2023-06-30 | $1.1M | 306k | 3.74 |
| 2023-03-31 | $938k | 280k | 3.35 |
| 2022-12-31 | $1.2M | 243k | 4.81 |
| 2022-06-30 | $1.6M | 227k | 7.10 |
| 2022-03-31 | $1.5M | 202k | 7.21 |
| 2021-12-31 | $2.5M | 280k | 8.94 |
| 2021-09-30 | $25M | 713k | 35.06 |
| 2021-03-31 | $16M | 254k | 61.76 |
| 2020-12-31 | $10M | 244k | 41.78 |